Moreover, a report titled ‘Convalescent Plasma Trial in COVID -19 Patients' (clinical trial no. NCT04356534) is also a randomized trial with an objective to compare plasma therapy using CP with an antibody against SARS-CoV-2 in COVID-19 patients with pneumonia and hypoxia and to find out whether there is any improvement in the clinical course. The gene discussed is CP; the disease is pneumonia.